Want the news summarized?
Subscribe to The Morning Report.

Biocom is out with its latest Deals and Data, a periodic roundup of the happenings in the local biotech world. Items include clinical trial news from locally based Vertex Pharmaceuticals on its Cystic Fibrosis drug, and Isis Pharmaceuticals on its prostate cancer drug. And it touches on the Amylin saga, which has been well chronicled in The Venture.

DAVID WASHBURN

Leave a comment

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.